InvestSMART

Invion Limited (ASX: IVX) - Announcements

Current share price for IVX : $0.037 0.001 (2.78%)+

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Invion subsidiary signs Supply Agreement with Pavay Biotech 30 Jun 2020 10:02AM $0.008 $0.037 risen by 362.50%
$4 Acceptance of New Zealand Patent Application 23 Jun 2020 8:25AM $0.007 $0.037 risen by 428.57%
$4 Program Update - March 2020 quarter 20 Apr 2020 11:32AM $0.009 $0.037 risen by 311.11%
$4 Appendix 4C - March 2020 quarter 20 Apr 2020 11:07AM $0.008 $0.037 risen by 362.50%
$4 Preliminary data links Photosoft with immune response 15 Apr 2020 8:19AM $0.008 $0.037 risen by 362.50%
$4 App 4D and Financial Report for half year to 31 Dec 2019 24 Feb 2020 4:03PM $0.010 $0.037 risen by 270%
$4 Photosoft data presented to Lorne Cancer Conference 14 Feb 2020 8:21AM $0.010 $0.037 risen by 270%
$4 Clarification to announcements of 3 February 2020 5 Feb 2020 12:30PM $0.011 $0.037 risen by 236.36%
$4 Lapse of unlisted share options 3 Feb 2020 8:23AM $0.012 $0.037 risen by 208.33%
$4 Invion signs R&D Services Agreement with Pavay Biotech 3 Feb 2020 8:23AM $0.012 $0.037 risen by 208.33%
$4 Appendix 4C December 2019 - cover note and market update 30 Jan 2020 8:26AM $0.012 $0.037 risen by 208.33%
$4 Appendix 4C - December 2019 quarter 30 Jan 2020 8:26AM $0.012 $0.037 risen by 208.33%
$4 App 3Z - Campbell - correction to date ceased to be director 9 Jan 2020 2:33PM $0.012 $0.037 risen by 208.33%
$4 MoU with Pavay on potential supply of dermatology compound 24 Dec 2019 8:40AM $0.013 $0.037 risen by 184.62%
$4 Final Directors Interest Notice - Campbell 23 Dec 2019 9:46AM $0.012 $0.037 risen by 208.33%
$4 Initial Directors Interest Notice - Farris 23 Dec 2019 9:45AM $0.012 $0.037 risen by 208.33%
$4 Change in Board and Management 23 Dec 2019 9:08AM $0.012 $0.037 risen by 208.33%
$4 Additional Information to Prior Announcement 29 Nov 2019 9:40AM $0.012 $0.037 risen by 208.33%
$4 Photosoft technology shrinks ovarian cancer in vivo 27 Nov 2019 8:20AM $0.008 $0.037 risen by 362.50%
$4 App 3X - Initial Directors Interest Notice - C Newton 4 Nov 2019 12:20PM $0.012 $0.037 risen by 208.33%
$4 App 3Z - Director's Final Interests Notice - G Collier 4 Nov 2019 12:18PM $0.012 $0.037 risen by 208.33%
$4 Results of AGM 4 Nov 2019 12:17PM $0.012 $0.037 risen by 208.33%
$4 App 3Y - Change of Directors Interest Notice - G Collier 4 Nov 2019 10:34AM $0.012 $0.037 risen by 208.33%
$4 Chairman's Address and CEO Presentation to Board 4 Nov 2019 10:19AM $0.012 $0.037 risen by 208.33%
$4 Appendix 3B - issue of options to incoming CEO 31 Oct 2019 2:17PM $0.013 $0.037 risen by 184.62%

401 - 425 of 717 results

Page 17 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.